UBS Group’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.86M Sell
132,735
-282,372
-68% -$3.8M ﹤0.01% 5042
2025
Q4
$4.66M Buy
415,107
+30,290
+8% +$347K ﹤0.01% 4101
2025
Q3
$4.45M Buy
384,817
+156,386
+68% +$1.83M ﹤0.01% 4153
2025
Q2
$2.8M Buy
228,431
+77,808
+52% +$978K ﹤0.01% 4461
2025
Q1
$2.16M Buy
150,623
+35,747
+31% +$558K ﹤0.01% 4635
2024
Q4
$1.83M Buy
114,876
+12,705
+12% +$251K ﹤0.01% 4806
2024
Q3
$2.46M Buy
102,171
+48,402
+90% +$1.11M ﹤0.01% 3803
2024
Q2
$1.07M Sell
53,769
-25,990
-33% -$506K ﹤0.01% 4360
2024
Q1
$1.59M Buy
79,759
+26,979
+51% +$522K ﹤0.01% 4166
2023
Q4
$1.18M Buy
52,780
+22,167
+72% +$458K ﹤0.01% 4347
2023
Q3
$619K Sell
30,613
-99,282
-76% -$2.25M ﹤0.01% 4494
2023
Q2
$3.32M Buy
129,895
+66,333
+104% +$1.75M ﹤0.01% 3001
2023
Q1
$1.89M Buy
63,562
+40,560
+176% +$1.18M ﹤0.01% 3494
2022
Q4
$622K Sell
23,002
-96
-0.4% -$2.35K ﹤0.01% 4513
2022
Q3
$503K Buy
23,098
+15,234
+194% +$398K ﹤0.01% 4334
2022
Q2
$215K Sell
7,864
-17,913
-69% -$515K ﹤0.01% 4848
2022
Q1
$863K Buy
25,777
+14,185
+122% +$457K ﹤0.01% 4250
2021
Q4
$402K Buy
11,592
+1,806
+18% +$58.4K ﹤0.01% 5160
2021
Q3
$305K Sell
9,786
-1,187
-11% -$40.3K ﹤0.01% 5031
2021
Q2
$399K Sell
10,973
-15,641
-59% -$647K ﹤0.01% 4891
2021
Q1
$1.16M Buy
26,614
+16,420
+161% +$771K ﹤0.01% 4099
2020
Q4
$468K Sell
10,194
-1,269
-11% -$52.8K ﹤0.01% 4655
2020
Q3
$381K Buy
11,463
+142
+1% +$4.54K ﹤0.01% 4375
2020
Q2
$333K Sell
11,321
-533
-4% -$15.4K ﹤0.01% 4438
2020
Q1
$319K Buy
11,854
+994
+9% +$29.7K ﹤0.01% 4345
2019
Q4
$366K Sell
10,860
-1,342
-11% -$48.6K ﹤0.01% 5118
2019
Q3
$457K Sell
12,202
-14,780
-55% -$564K ﹤0.01% 4641
2019
Q2
$1.18M Sell
26,982
-28,917
-52% -$1.24M ﹤0.01% 3620
2019
Q1
$2.38M Buy
55,899
+26,173
+88% +$1.17M ﹤0.01% 2840
2018
Q4
$1.33M Sell
29,726
-60,003
-67% -$3.14M ﹤0.01% 3423
2018
Q3
$6.15M Buy
89,729
+27,802
+45% +$1.79M ﹤0.01% 2178
2018
Q2
$3.54M Sell
61,927
-37,066
-37% -$1.96M ﹤0.01% 2642
2018
Q1
$4.56M Buy
98,993
+39,728
+67% +$1.89M ﹤0.01% 2394
2017
Q4
$2.74M Sell
59,265
-12,253
-17% -$563K ﹤0.01% 2913
2017
Q3
$3.22M Sell
71,518
-35,609
-33% -$1.52M ﹤0.01% 2639
2017
Q2
$4.21M Buy
107,127
+9,542
+10% +$361K ﹤0.01% 2306
2017
Q1
$3.72M Buy
97,585
+23,819
+32% +$928K ﹤0.01% 2348
2016
Q4
$2.73M Buy
73,766
+10,393
+16% +$371K ﹤0.01% 2630
2016
Q3
$2.2M Sell
63,373
-30,966
-33% -$1.08M ﹤0.01% 2754
2016
Q2
$3.07M Sell
94,339
-9,517
-9% -$292K ﹤0.01% 2410
2016
Q1
$2.98M Sell
103,856
-24,521
-19% -$653K ﹤0.01% 2324
2015
Q4
$4.29M Sell
128,377
-82,640
-39% -$2.57M ﹤0.01% 2095
2015
Q3
$6M Sell
211,017
-31,730
-13% -$1.11M 0.01% 1757
2015
Q2
$9.83M Buy
242,747
+41,714
+21% +$1.87M 0.01% 1490
2015
Q1
$9.89M Sell
201,033
-23,388
-10% -$1.08M 0.01% 1486
2014
Q4
$10.2M Buy
+224,421
New +$8.82M 0.01% 1493

Other funds holding AVNS